PCK1 and neoplasm: These results indicate that the Insig1/2 loop 1 peptide binds to S90‐phosphorylated PCK1 and blocks PCK1‐mediated SREBP activation, SREBP‐downstream gene expression, de novo lipogenesis, and tumor cell proliferation.